Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-190-3 | CAS number: 306-83-2
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
HCFC 123 has a low acute toxicity following oral, dermal and inhalatory exposure. However, signs of CNS depression and sublethal toxic changes in the liver were observed in acute toxicity experiments.
Oral exposure
An approximate lethal concentration of 9000 mg/kg in male rats administered via gavage was reported by Haskell (1975).
Inhalation
Studies in rats, hamsters and guinea pigs are available. 4 -h exposure in rats (ECETOC, 2005) and hamsters (Allied Signal, 1981) gave consistent results with LC50 of 32000 and 28400 ppm, respectively. CNS depression was observed to occur during the exposure period in those studies, with full recovery of the surviving animals shortly after the cessation of the exposure.
No lethality was observed in guinea pigs exposed up to 30000 ppm for 4 hours, but hepatoxicity was observed at 1000 ppm and above (Marit et al., 1994).
Dermal exposure
Acute dermal toxicity was studied in rats (Haskell, 1988a) and rabbits (Haskell, 1988b). In both studies, no lethality was observed up to the highest tested dose of 2000 mg/kg. No clinical signs were noted in the rabbit study, whereas red nasal and ocular discharges were noted in 2 rats exposed to 2000 mg/kg. No signs of skin irritation were recorded. A slight bodyweight loss was also observed at the end of the 14 -day recovery period.
Justification for classification or non-classification
HCFC 123 does not meet the criteria for acute toxicity classification in accordance with EU Directive 67/548/EEC and EU Classification, Labeling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
In accordance with Directive 67/548/EEC, HCFC 123 is classified as Harmful - possible risk of irreversible effects (Xn R68/20) in view of the significant hepatotoxicity observed in guinea pigs and to the reported data in humans (see Section 7.10.5)
In accordance with Regulation EC 1272/2008 HCFC 123 is classifiable as STOT-SE Category 2 (H371) in view of the weight of evidence (significant hepatotoxicity observed in guinea pigs and reported human data).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
